← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

CEO Michael Kauffman sold $240K of Karyopharm Therapeutics Inc.

Sold$240,000
$12.00Price
20,000Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Fri, Nov 1. Filed Tue, Nov 5, 11:08 AM ET, during the session. Not investment advice.